Medicure - News Releases

Get News Alerts by Email

Aug 15, 2018

Medicure Reports Financial Results for Quarter Ended June 30, 2018
Aug 13, 2018

Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection
Aug 8, 2018

Medicure Q2 2018 Results and Conference Call Dates
May 23, 2018

Medicure Reports Financial Results for Quarter Ended March 31, 2018
May 17, 2018

Medicure Q1 2018 Results and Conference Call Dates
May 17, 2018

Medicure Announces Normal Course Issuer Bid
May 1, 2018

Medicure Reports Financial Results for Quarter and Year Ended December 31, 2017
May 1, 2018

Medicure announces availability of ZYPITAMAG™ (pitavastatin) in the U.S.
Apr 24, 2018

Medicure to Announce Fiscal Year End 2017 Financial Results on April 30, 2018
Mar 28, 2018

Medicure Announces Further Up-Date on PREXXARTAN®
Mar 19, 2018

Medicure Announces an Up-Date on PREXXARTAN® Launch
Mar 7, 2018

Zydus partners with Medicure to launch its NDA Product, ZYPITAMAG (pitavastatin) in the U.S.
Feb 1, 2018

Medicure Announces Receipt of Deferred Proceeds from Apicore Sale
Dec 19, 2017

Medicure Announces FDA Approval Received for Prexxartan®
Dec 14, 2017

Medicure Acquires Exclusive License to Sell and Market Branded Cardiovascular Drug in the U.S.
Nov 21, 2017

Medicure Reports Financial Results for Quarter Ended September 30, 2017
Nov 17, 2017

Medicure Announces Repayment of Outstanding Debt
Nov 15, 2017

Medicure Q3 Results and Conference Call Dates
Oct 31, 2017

Medicure Acquires Exclusive License to Sell and Market PREXXARTAN® in the U.S. from Carmel Biosciences
Oct 3, 2017

Medicure Announces Sale of Apicore Business
Aug 7, 2017

Medicure Reports Financial Results for Quarter Ended June 30, 2017
Aug 2, 2017

Medicure Q2 Results and Conference Call Dates
Jul 12, 2017

Medicure Closes Acquisition of Additional Interests in Apicore
Jul 10, 2017

Medicure Exercises Option to Acquire Additional Interests in Apicore
Jul 3, 2017

Medicure Provides Update on Apicore Purchase Option

Show per page

print